These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 16766045)
1. IVIg attenuates T cell-mediated killing of human neurons. Janke AD; Giuliani F; Yong VW J Neuroimmunol; 2006 Aug; 177(1-2):181-8. PubMed ID: 16766045 [TBL] [Abstract][Full Text] [Related]
2. Synergistic effects on the inhibition of human CD8+ cytotoxic T lymphocytes-mediated killing against xenograft cells by coexpression of membrane-bound Human FasL and decoy Fas antigen. Tanemura M; Kawamoto K; Ito T; Uchikoshi F; Shimada K; Nishida T; Matsuda H Transplant Proc; 2005 Dec; 37(10):4607-9. PubMed ID: 16387181 [TBL] [Abstract][Full Text] [Related]
3. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen. Kawamoto K; Tanemura M; Nishida T; Fukuzawa M; Ito T; Matsuda H Transplantation; 2006 Mar; 81(5):789-96. PubMed ID: 16534484 [TBL] [Abstract][Full Text] [Related]
4. Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis. Julià E; Montalban X; Al-Zayat H; Issazadeh-Navikas S; Goertsches R; Martin R; Comabella M J Neuroimmunol; 2006 Nov; 180(1-2):147-58. PubMed ID: 16899302 [TBL] [Abstract][Full Text] [Related]
5. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [TBL] [Abstract][Full Text] [Related]
6. Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors. Tha-In T; Metselaar HJ; Tilanus HW; Boor PP; Mancham S; Kuipers EJ; de Man RA; Kwekkeboom J Transplantation; 2006 Jun; 81(12):1725-34. PubMed ID: 16794540 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin G-mediated inhibition of T-cell proliferation reflects an endogenous mechanism by which IgG modulates T-cell activation. MacMillan HF; Lee T; Issekutz AC Clin Immunol; 2009 Aug; 132(2):222-33. PubMed ID: 19447680 [TBL] [Abstract][Full Text] [Related]
8. Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction. Giuliani F; Hader W; Yong VW J Leukoc Biol; 2005 Jul; 78(1):135-43. PubMed ID: 15817702 [TBL] [Abstract][Full Text] [Related]
9. In vitro effects of an immunoglobulin preparation for intravenous use (IVIG) on T-cells activation. Sbrana S; Ruocco L; Vanacore R; Azzarà A; Ambrogi F Allerg Immunol (Paris); 1993 Jan; 25(1):35-7. PubMed ID: 8471137 [TBL] [Abstract][Full Text] [Related]
10. The dual role of Fas-ligand as an injury effector and defense strategy in diabetes and islet transplantation. Pearl-Yafe M; Yolcu ES; Yaniv I; Stein J; Shirwan H; Askenasy N Bioessays; 2006 Feb; 28(2):211-22. PubMed ID: 16435302 [TBL] [Abstract][Full Text] [Related]
11. Variation of anti-Fas antibodies in different lots of intravenous immunoglobulin. Reipert BM; Stellamor MT; Poell M; Ilas J; Sasgary M; Reipert S; Zimmermann K; Ehrlich H; Schwarz HP Vox Sang; 2008 May; 94(4):334-41. PubMed ID: 18266779 [TBL] [Abstract][Full Text] [Related]
12. Intravenous polyclonal human immunoglobulins in multiple sclerosis. Soelberg Sorensen P Neurodegener Dis; 2008; 5(1):8-15. PubMed ID: 18075269 [TBL] [Abstract][Full Text] [Related]
13. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis. Hamamcioglu K; Reder AT Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069 [TBL] [Abstract][Full Text] [Related]
14. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. Dupont PJ; Warrens AN Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740 [TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ; Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164 [TBL] [Abstract][Full Text] [Related]
16. Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells. Mohamood AS; Trujillo CJ; Zheng D; Jie C; Murillo FM; Schneck JP; Hamad AR Int Immunol; 2006 Aug; 18(8):1265-77. PubMed ID: 16769751 [TBL] [Abstract][Full Text] [Related]
17. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells. Korporal M; Haas J; Balint B; Fritzsching B; Schwarz A; Moeller S; Fritz B; Suri-Payer E; Wildemann B Arch Neurol; 2008 Nov; 65(11):1434-9. PubMed ID: 19001161 [TBL] [Abstract][Full Text] [Related]
18. Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals. Fritzsching B; Korporal M; Haas J; Krammer PH; Suri-Payer E; Wildemann B J Neurol Sci; 2006 Dec; 251(1-2):91-7. PubMed ID: 17092518 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells. Lin SJ; Lee CC; Cheng PJ; See LC; Kuo ML Pediatr Allergy Immunol; 2009 Jun; 20(4):392-8. PubMed ID: 18713315 [TBL] [Abstract][Full Text] [Related]
20. Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis. Coisne C; Mao W; Engelhardt B J Immunol; 2009 May; 182(10):5909-13. PubMed ID: 19414741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]